Active Ingredient(s): Maribavir
FDA Approved: * November 23, 2021
Pharm Company: * TAKEDA PHARMS USA
Category: Antiviral

Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV).[1][2] The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue.[2] Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication.[2] Maribavir was approved f... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Livtencity 200 mg Oral Tablet, Coated
NDC: 64764-800
Takeda Pharmaceuticals America, Inc.